Income Statement (TTM)
Galderma Group AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 12-31 |
2022 12-31 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,445 | 3,824 | 4,117 | 4,218 | 4,318 | 4,379 | 4,440 | 4,565 | 4,690 |
| Change (%) | 11.00 | 7.66 | 2.44 | 2.38 | 1.41 | 1.39 | 2.82 | 2.74 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,034 | 1,194 | 1,232 | 1,274 | 1,315 | 1,335 | 1,355 | 1,400 | 1,444 |
| Change (%) | 15.49 | 3.18 | 3.37 | 3.26 | 1.52 | 1.50 | 3.28 | 3.18 | |
| % of Revenue | 30.01 | 31.22 | 29.92 | 30.20 | 30.45 | 30.49 | 30.52 | 30.66 | 30.79 |
| Gross Operating Profit | 2,411 | 2,630 | 2,885 | 2,944 | 3,003 | 3,044 | 3,085 | 3,166 | 3,246 |
| Change (%) | 9.07 | 9.70 | 2.05 | 2.00 | 1.37 | 1.35 | 2.61 | 2.54 | |
| % of Revenue | 69.99 | 68.78 | 70.08 | 69.80 | 69.55 | 69.51 | 69.48 | 69.34 | 69.21 |
| SG&A | 1,711 | 1,908 | 1,990 | 2,039 | 2,088 | 2,118 | 2,151 | 2,208 | 2,264 |
| Change (%) | 11.49 | 4.30 | 2.46 | 2.40 | 1.41 | 1.58 | 2.63 | 2.56 | |
| % of Revenue | 49.67 | 49.90 | 48.34 | 48.35 | 48.36 | 48.36 | 48.45 | 48.36 | 48.27 |
| R&D | 343 | 316 | 287 | 286 | 285 | 272 | 260 | 244 | 229 |
| Change (%) | -7.79 | -9.15 | -0.35 | -0.35 | -4.39 | -4.59 | -5.96 | -6.34 | |
| % of Revenue | 9.94 | 8.26 | 6.97 | 6.78 | 6.60 | 6.22 | 5.86 | 5.36 | 4.88 |
| OpEx | 3,096 | 3,423 | 3,511 | 3,600 | 3,689 | 3,727 | 3,769 | 3,858 | 3,947 |
| Change (%) | 10.58 | 2.57 | 2.53 | 2.47 | 1.03 | 1.13 | 2.36 | 2.31 | |
| % of Revenue | 89.85 | 89.52 | 85.28 | 85.36 | 85.43 | 85.11 | 84.89 | 84.51 | 84.16 |
| Operating Income | 350 | 401 | 606 | 618 | 629 | 652 | 671 | 707 | 743 |
| Change (%) | 14.71 | 51.16 | 1.90 | 1.86 | 3.66 | 2.91 | 5.37 | 5.09 | |
| % of Revenue | 10.15 | 10.48 | 14.72 | 14.64 | 14.57 | 14.89 | 15.11 | 15.49 | 15.84 |
| Interest Expense | -353 | -398 | -561 | -530 | -498 | -421 | -352 | -283 | -214 |
| Change (%) | 12.96 | 40.81 | -5.61 | -5.95 | -15.46 | -16.39 | -19.60 | -24.38 | |
| % of Revenue | -10.24 | -10.42 | -13.63 | -12.55 | -11.53 | -9.61 | -7.93 | -6.20 | -4.56 |
| Net Income | -154 | -98 | -57 | -36 | -14 | 108 | 231 | 304 | 378 |
| Change (%) | -36.16 | -42.13 | -37.72 | -60.56 | -875.00 | 112.90 | 31.82 | 24.14 | |
| % of Revenue | -4.48 | -2.58 | -1.38 | -0.84 | -0.32 | 2.48 | 5.20 | 6.67 | 8.06 |
Source: Capital IQ
